Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

This study has been completed.
Sponsor:
Collaborator:
Nissho Nipro Europe
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00230906
First received: September 29, 2005
Last updated: December 19, 2007
Last verified: December 2007
  Purpose

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane


Condition Intervention
Haemodialysis
Procedure: Haemodialysis with either low or high flux membranes

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Uremic Toxin Removal With a New High Flux Cellulose Triacetate Membrane

Resource links provided by NLM:


Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Concentration of uremic components after 3 weeks of haemodialysis

Estimated Enrollment: 12
Study Start Date: January 2001
Study Completion Date: April 2002
Detailed Description:

Comparison of the uremic toxin removal by haemodialysis either with a low flux or a new high flux cellulose triacetate membrane

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Chronic haemodialysis patient
  • Serum albumin > 3.6 g/dl

Exclusion Criteria:

  • < 18 years
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230906

Locations
Belgium
University Hospital Ghent
Ghent, Belgium, 9000
Sponsors and Collaborators
University Hospital, Ghent
Nissho Nipro Europe
Investigators
Principal Investigator: Raymond Van Holder, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
No publications provided

ClinicalTrials.gov Identifier: NCT00230906     History of Changes
Other Study ID Numbers: 2001/182
Study First Received: September 29, 2005
Last Updated: December 19, 2007
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on April 23, 2014